| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Pathology, Tohoku University School of Medicine (H.I., T.S., T.M., C.K., H.S.); Department of Thoracic Surgery, Institute of Development, Aging, and Cancer, Tohoku University (S.S., T.K.); and Department of Surgery, Sendai Kousei Hospital (M.H.), Sendai 980-8575, Japan; and Departments of Pathology (T.T.) and Thoracic Cardiovascular Surgery (H.I., M.S.), Graduate School, Tokyo Medical and Dental University, Tokyo 113-0034, Japan
Address all correspondence and requests for reprints to: Hironori Ishibashi, M.D., Department of Pathology, Tohoku University School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi Prefecture, 980-8575, Japan. E-mail: hishiba{at}kf6.so-net.ne.jp.
In this study we examined the immunohistochemical localization of sex steroid receptors for estrogen
(ER
) and ERß, progesterone-A (PR-A) and PR-B, and androgen (AR) in human thymoma (n = 132) and correlated these findings with various clinicopathological parameters. We used RT-PCR and real-time PCR to further study the expression of these receptors in 20 thymoma cases. Immunoreactivity for all sex steroid receptors was detected in the nuclei of thymoma epithelial cells. The percentage of immunopositive cases and the H-score values for each receptor (mean ± SD) were: ER
, 66% and 85.8 ± 80.2; ERß, 7% and 7.2 ± 8.7; PR-A, 4% and 2.7 ± 4.9; PR-B, 49% and 55.8 ± 68.3; and AR, 15% and 14.1 ± 11.7, respectively. The results of real-time PCR were consistent with those of immunohistochemistry, especially results for ER
, PR-B, and AR. A significant positive correlation was detected between immunoreactivity for ER
and PR-B. ER
immunoreactivity was inversely correlated with tumor size, clinical stage, WHO classification, and Ki-67 labeling index. In addition, the status of ER
immunoreactivity was significantly associated with a better clinical outcome in thymoma patients. Results from our study suggest that estrogens may inhibit thymoma growth via ER
, and that ER
immunoreactivity may act as a prognostic factor in human thymoma.
Abbreviations: AR, Androgen receptor; ER, estrogen receptor; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; ir, immunoreactivity; LI, labeling index; PR, progesterone receptor.
This article has been cited by other articles:
![]() |
O. Bukulmez, D. B. Hardy, B. R. Carr, R. A. Word, and C. R. Mendelson Inflammatory Status Influences Aromatase and Steroid Receptor Expression in Endometriosis Endocrinology, March 1, 2008; 149(3): 1190 - 1204. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Condon, D. B. Hardy, K. Kovaric, and C. R. Mendelson Up-Regulation of the Progesterone Receptor (PR)-C Isoform in Laboring Myometrium by Activation of Nuclear Factor-{kappa}B May Contribute to the Onset of Labor through Inhibition of PR Function Mol. Endocrinol., April 1, 2006; 20(4): 764 - 775. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ishibashi, T. Suzuki, S. Suzuki, T. Moriya, C. Kaneko, T. Nakata, M. Sunamori, M. Handa, T. Kondo, and H. Sasano Estrogen Inhibits Cell Proliferation through In situ Production in Human Thymoma Clin. Cancer Res., September 15, 2005; 11(18): 6495 - 6504. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ferolla, A. Falchetti, P. Filosso, P. Tomassetti, G. Tamburrano, N. Avenia, G. Daddi, F. Puma, R. Ribacchi, F. Santeusanio, et al. Thymic Neuroendocrine Carcinoma (Carcinoid) in Multiple Endocrine Neoplasia Type 1 Syndrome: The Italian Series J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2603 - 2609. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |